West Pharmaceutical Services (NYSE: WST) is a global manufacturer that designs and produces containment and delivery systems for injectable drugs and healthcare products. It makes money by selling proprietary packaging components, drug delivery devices, and integrated systems to pharmaceutical and biotech customers, alongside a contract manufacturing and analytical lab services segment. The business operates through two reportable segments: Proprietary Products and Contract-Manufactured Products, as disclosed in the 10-K filed 2026-02-17. Customers include biologic, generic, pharmaceutical, diagnostic, and medical device companies. The Proprietary Products segment covers elastomers and primary containment, drug delivery devices, integrated systems, and analytical lab services. Switching costs are embedded in the business: customers qualify West's components for specific drug formulations through regulatory processes, making substitution costly and slow. The filing characterizes the company as a global manufacturer focused on quality, scientific expertise, and manufacturing precision as the basis for customer partnerships.

Revenue model

Transactional product sales across two segments: Proprietary Products (elastomers, primary containment, drug delivery devices, integrated systems, analytical lab services sold primarily to biologic, generic, and pharmaceutical customers) and Contract-Manufactured Products (contract manufacturing services). Revenue is tied to drug production volumes at customer facilities.

Products and services

Proprietary packaging components including stoppers and closures (elastomers and primary containment), drug delivery devices, reconstitution and transfer systems, integrated containment and delivery systems, analytical lab services, and contract manufacturing for healthcare products.

Customers and end markets

Biologic drug manufacturers, generic pharmaceutical companies, branded pharmaceutical companies, diagnostic companies, and medical device companies. End market is injectable drug packaging and delivery. Customer base described as global and includes companies the filing characterizes as leading in their respective categories.

Value-chain role

Upstream component supplier to pharmaceutical and biotech manufacturers. West sits between raw material suppliers and drug manufacturers, providing primary packaging and delivery components that are in direct contact with drug products and must meet regulatory quality standards.

Geographic exposure

Global operations. The filing describes West as a global manufacturer but does not provide specific regional revenue breakdowns in the excerpts provided.

Source: SEC 10-K, filed 2026-02-17

Industry: Surgical & Medical Instruments & Apparatus Peers: Agilent Technologies Inc Avantor Inc Bio Rad Laboratories Inc Danaher Corp Revvity Inc Illumina Inc IQVIA Holdings Inc Mettler-toledo International Inc Thermo Fisher Scientific Inc Waters Corp